MedTrace Logo

Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits

NCT04328207 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2025-08-07

Study results available
· View outcomes & findings →

Summary

Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform to manage this disease in community-based clinics so that further vision loss is prevented. Our goal is to improve the quality and accessibility of glaucoma detection and management among a vulnerable and at-risk segment of our population.

Conditions

Interventions

OTHER

No Financial Incentive

Standard of care eye health education

BEHAVIORAL

Financial Incentive

Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.

Sponsors & Collaborators

Principal Investigators

  • Christopher A Girkin, MD, MSPH · University of Alabama at Birmingham

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-18
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04328207 on ClinicalTrials.gov